阿米卡星治疗ICU病房中肺部感染的疗效观察

Clinical effect of amikacin on pulmonary infection in ICU ward

目的:探讨阿米卡星治疗ICU病房中肺部感染的临床疗效.方法:选取本院ICU病房中肺部感染患者54例作为研究对象,将其随机分为研究组(28例)和对照组(26例).研究组患者给予阿米卡星治疗,对照组患者给予阿莫西林治疗.比较两组患者治疗后的临床疗效.结果:阿米卡星组治疗后的总有效率为92.86%,阿莫西林组治疗后的总有效率为73.08%,比较两组患者治疗后的总有效率,差异有统计学意义(P<0.05).结论:对ICU病房中的肺部感染患者实施阿米卡星治疗疗效显著,值得临床推广.

AIM： To investigate the clinical effect of Amikaein in the treatment of pulmonary infection in ICU ward. METH- ODS： A total of 54 patients with pulmonary infection admitted into our hospital were randomly divided into study group and control group, 28 cases in the study group and 26 cases in the control group, the study group were treated with amikacin, and the control group was treated with amoxicillin. The clinical efficacy of the two groups after treatment was compared. RESULTS ： The total effective rate was 92.86% after treatment in the study group, while the total effective rate was 73.08% after treatment in the control group, the difference between two groups was statistically significant （ P 〈 0.05 ）, CONCLUSION： The effect of amikacin in the treatment of patients with pulmonary infection in ICU ward is significant, and it is worthy of clinical promotion.